A Safety and Efficacy Study of Inhaled Fluticasone Propionate/Salmeterol Combination versus Inhaled Fluticasone Propionate in the Treatment of Adolescent and Adult Subjects with Asthma
-
- STATUS
- Not Recruiting
Summary
This study is a randomized, double-blind, stratified, parallel-group, multicenter study, 26 weeks in duration, that is designed to evaluate the non-inferiority of fluticasone propionate/salmeterol combination versus fluticasone propionate on the composite endpoint of serious asthma outcomes (asthma-related hospitalization, endotracheal intubation, and death) in subjects with asthma.
Description
This study is a randomized, double-blind, stratified, parallel-group, multicenter study, 26 weeks in duration, that is designed to evaluate the non-inferiority of fluticasone propionate/salmeterol combination versus fluticasone propionate on the composite endpoint of serious asthma outcomes (asthma-related hospitalization, endotracheal intubation, and death) in subjects with asthma.
Details
| Condition | Asthma |
|---|---|
| Age | 12years - 100years |
| Clinical Study Identifier | TX3587 |
| Last Modified on | 19 February 2024 |
Similar trials to consider
Not finding what you're looking for?
Sign up as a volunteer to stay informed
Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.
Sign up as volunteerStudy Definition
WikipediaAdd a private note
- Select a piece of text.
- Add notes visible only to you.
- Send it to people through a passcode protected link.